A joint effort – the pivotal role of pharmacists in joint pain management Pharmacists have an important role to play in the management of osteoarthritis and joint pain, but they also face significant barriers to becoming integrated within the multidisciplinary team.… Supported content
How to conduct an effective joint pain management consultation in a community pharmacy setting A guide to help community pharmacy team members effectively engage in conversations with patients about joint pain symptoms.… Supported content
Community pharmacy teams can provide greater support to patients presenting with joint pain, regardless of diagnosis Rheumatologist Philip Conaghan urges pharmacists to take on a greater front line role when managing patients who present with joint pain.… Supported content
Experts to develop referral pathway to aid joint pain management in community pharmacy Addressing the learning needs of pharmacy teams to enhance and standardise care of patients who present with joint pain in community pharmacy.… Supported content
A painless first step Much can be done to improve the quality of life for patients presenting to their community pharmacy with joint pain.… Supported content
Managing plantar heel pain in the pharmacy How to differentiate plantar fasciopathy from other causes of plantar heel pain, advice for pharmacists on counselling patients and when to refer. … Supported content
No evidence vitamin D supplements improve bone health, major analysis finds Vitamin D supplements for adults do not prevent fractures, falls or improve bone mineral density, according to authors of the biggest review of evidence to date.…
Alendronate may lower cardiovascular risk in hip fracture patients Study finds a treatment for osteoporosis may reduce the risk of cardiovascular events in people with hip fractures.…
Help us understand your experience of supporting patients with osteoarthritis The Pharmaceutical Journal launches insight-led campaign to advance pharmacy’s role in management of osteoarthritis.…
Halting TNF-inhibitors in rheumatoid arthritis patients in remission could lead to significant savings, research reveals Stopping tumour necrosis factor inhibitors in rheumatoid arthritis patients who are in remission or have low disease activity was associated with savings of more than €7,000.…
